Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017

Tuesday, July 11, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

LOVELAND, Colo., July 11, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company"),

a provider of advanced veterinary diagnostic and specialty products, plans to announce its second quarter 2017 financial results in a press release to be issued on Monday, July 31, 2017 before the market opens. The Company
plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Monday, July 31, 2017.

To access the conference call:

From within the United States, please dial 1-888-539-3624From outside of the United States, please dial 1-719-325-2468Reference Conference ID: 9569010

The conference call will be webcast live from the Company's website on www.heska.com.

A telephonic replay of the conference call will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Monday, August 7, 2017.

To access the replay:

From within the United States, please dial 1-844-512-2921From outside the United States, please dial 1-412-317-6671Reference Replay Pin Number: 9569010

The webcast will also be archived on www.heska.com for 90 days.

About HeskaHeska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, vaccines, local and cloud-based data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space. For further information on Heska and its products, visit www.heska.com.

 

View original content:http://www.prnewswire.com/news-releases/heska-schedules-second-quarter-2017-financial-results-conference-call-for-july-31-2017-300485677.html

SOURCE Heska Corporation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook